Ligand Pharmaceuticals Incorporated (LGND) vs Travere Therapeutics, Inc. (TVTX)
Ligand Pharmaceuticals Incorporated and Travere Therapeutics, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Travere Therapeutics, Inc. are of similar size ($6.1B and $5.7B). Travere Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 77.1% against 54.9%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −7.35%) and the higher return on invested capital (8.19% vs −18.3%). Across the 20 metrics below, Ligand Pharmaceuticals Incorporated leads on 15 and Travere Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | LGND | TVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.43% | 98.60% | 65.16% |
| Operating margin | 32.61% | (6.84%) | 0.00% |
| Net margin | 67.88% | (7.35%) | 0.00% |
| Free cash flow margin | 49.34% | 2.56% | 0.00% |
| Return on equity | 21.96% | (151.79%) | (57.72%) |
| Return on assets | 12.58% | (6.42%) | (49.22%) |
| Return on invested capital | 8.19% | (18.31%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack